BeyondSpring (NASDAQ:BYSI) Stock Price Down 1% – Here’s What Happened

Shares of BeyondSpring Inc. (NASDAQ:BYSI) traded down 1% during mid-day trading on Tuesday . The company traded as low as $2.12 and last traded at $2.12. 16,276 shares traded hands during trading, a decline of 82% from the average session volume of 91,642 shares. The stock had previously closed at $2.14.

BeyondSpring Stock Performance

The firm’s 50 day simple moving average is $2.21 and its 200 day simple moving average is $2.28.

Institutional Trading of BeyondSpring

An institutional investor recently bought a new position in BeyondSpring stock. SG Americas Securities LLC purchased a new position in BeyondSpring Inc. (NASDAQ:BYSI) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 17,539 shares of the company’s stock, valued at approximately $63,000. Hedge funds and other institutional investors own 40.29% of the company’s stock.

About BeyondSpring

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.